These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33992716)

  • 1. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines.
    Wiercioch W; Nieuwlaat R; Dahm P; Iorio A; Mustafa RA; Neumann I; Rochwerg B; Manja V; Alonso-Coello P; Ortel TL; Santesso N; Vesely SK; Akl EA; Schünemann HJ;
    J Clin Epidemiol; 2021 Oct; 138():115-127. PubMed ID: 33992716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New methods facilitated the process of prioritizing questions and health outcomes in guideline development.
    Wiercioch W; Nieuwlaat R; Zhang Y; Alonso-Coello P; Dahm P; Iorio A; Manja V; Mustafa RA; Neumann I; Ortel TL; Rochwerg B; Santesso N; Vesely SK; Akl EA; Schünemann HJ
    J Clin Epidemiol; 2022 Mar; 143():91-104. PubMed ID: 34843861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence to Decision framework provides a structured "roadmap" for making GRADE guidelines recommendations.
    Li SA; Alexander PE; Reljic T; Cuker A; Nieuwlaat R; Wiercioch W; Guyatt G; Schünemann HJ; Djulbegovic B
    J Clin Epidemiol; 2018 Dec; 104():103-112. PubMed ID: 30253221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured decision-making drives guidelines panels' recommendations "for" but not "against" health interventions.
    Djulbegovic B; Reljic T; Elqayam S; Cuker A; Hozo I; Zhou Q; Li SA; Alexander P; Nieuwlaat R; Wiercioch W; Schünemann H; Guyatt G
    J Clin Epidemiol; 2019 Jun; 110():23-33. PubMed ID: 30779950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using GRADE evidence to decision frameworks to choose from multiple interventions.
    Piggott T; Brozek J; Nowak A; Dietl H; Dietl B; Saz-Parkinson Z; Mirzayev F; González-Angulo L; Yepes-Nuñez JJ; Mustafa RA; Leontiadis GI; Brignardello-Petersen R; Alonso-Coello P; Schünemann HJ
    J Clin Epidemiol; 2021 Feb; 130():117-124. PubMed ID: 33127374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GRADE: Using evidence to decision frameworks for adoption, adaptation and de novo generation of trustworthy guideline recommendations - GRADE-ADOLOPMENT].
    Kallenbach M; Conrad S; Hoffmann F; Matthias K; Gartlehner G; Langer G; Meerpohl J
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():90-99. PubMed ID: 31399391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 2 - Using qualitative evidence synthesis findings to inform evidence-to-decision frameworks and recommendations.
    Lewin S; Glenton C; Lawrie TA; Downe S; Finlayson KW; Rosenbaum S; Barreix M; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):75. PubMed ID: 31391119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.
    Schünemann HJ; Wiercioch W; Brozek J; Etxeandia-Ikobaltzeta I; Mustafa RA; Manja V; Brignardello-Petersen R; Neumann I; Falavigna M; Alhazzani W; Santesso N; Zhang Y; Meerpohl JJ; Morgan RL; Rochwerg B; Darzi A; Rojas MX; Carrasco-Labra A; Adi Y; AlRayees Z; Riva J; Bollig C; Moore A; Yepes-Nuñez JJ; Cuello C; Waziry R; Akl EA
    J Clin Epidemiol; 2017 Jan; 81():101-110. PubMed ID: 27713072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversy and Debate Series on Core Outcome Sets. Paper 3: Debate on Paper 1 from the perspective of GRADE [Grading of Recommendations Assessment, Development and Evaluation].
    Schünemann HJ; Tunis S; Nieuwlaat R; Wiercioch W; Baldeh T
    J Clin Epidemiol; 2020 Sep; 125():216-221. PubMed ID: 32438026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring importance of outcomes to patients: a cross-sectional survey for the German anal cancer guideline.
    Werner RN; Gaskins M; Dressler C; Nast A; Schaefer C; Aigner F; Siegel R
    J Clin Epidemiol; 2021 Jan; 129():40-50. PubMed ID: 32987160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certainty of evidence and intervention's benefits and harms are key determinants of guidelines' recommendations.
    Djulbegovic B; Hozo I; Li SA; Razavi M; Cuker A; Guyatt G
    J Clin Epidemiol; 2021 Aug; 136():1-9. PubMed ID: 33662511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and use of health outcome descriptors: a guideline development case study.
    Baldeh T; Saz-Parkinson Z; Muti P; Santesso N; Morgano GP; Wiercioch W; Nieuwlaat R; Gräwingholt A; Broeders M; Duffy S; Hofvind S; Nystrom L; Ioannidou-Mouzaka L; Warman S; McGarrigle H; Knox S; Fitzpatrick P; Rossi PG; Quinn C; Borisch B; Lebeau A; de Wolf C; Langendam M; Piggott T; Giordano L; van Landsveld-Verhoeven C; Bernier J; Rabe P; Schünemann HJ
    Health Qual Life Outcomes; 2020 Jun; 18(1):167. PubMed ID: 32503619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.
    Zhang Y; Coello PA; Brożek J; Wiercioch W; Etxeandia-Ikobaltzeta I; Akl EA; Meerpohl JJ; Alhazzani W; Carrasco-Labra A; Morgan RL; Mustafa RA; Riva JJ; Moore A; Yepes-Nuñez JJ; Cuello-Garcia C; AlRayees Z; Manja V; Falavigna M; Neumann I; Brignardello-Petersen R; Santesso N; Rochwerg B; Darzi A; Rojas MX; Adi Y; Bollig C; Waziry R; Schünemann HJ
    Health Qual Life Outcomes; 2017 May; 15(1):52. PubMed ID: 28460638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative study of guideline panelists: innovative surveys provided valuable insights regarding patient values and preferences.
    Zeng L; Li SA; Yang M; Yan L; Helsingen LM; Bretthauer M; Agoritsas T; Vandvik PO; Mustafa RA; Busse J; Siemieniuk RAC; Lytvyn L; Zhang L; Brignardello-Petersen R; Guyatt GH
    J Clin Epidemiol; 2023 Sep; 161():173-180. PubMed ID: 37517505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial.
    Vandvik PO; Santesso N; Akl EA; You J; Mulla S; Spencer FA; Johnston BC; Brozek J; Kreis J; Brandt L; Zhou Q; Schünemann HJ; Guyatt G
    J Clin Epidemiol; 2012 Jul; 65(7):748-55. PubMed ID: 22564503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decomposing clinical practice guidelines panels' deliberation into decision theoretical constructs.
    Djulbegovic B; Hozo I; Lizarraga D; Guyatt G
    J Eval Clin Pract; 2023 Apr; 29(3):459-471. PubMed ID: 36694469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].
    Zawilska K; Jaeschke R; Tomkowski W; Mayzner-Zawadzka E; Nizankowski R; Olejek A; Pasierski T; Torbicki A; Undas A; Jawień A; Gajewski P; Sznajd J; Brozek J;
    Pol Arch Med Wewn; 2009; 119 Suppl 1():1-69. PubMed ID: 19841614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.